Browse our anti-TNFRSF10C (TNFRSF10C) Antibodies

Full name:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain Antibodies (TNFRSF10C)
On are 150 Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) Antibodies from 20 different suppliers available. Additionally we are shipping TNFRSF10C Proteins (11) and TNFRSF10C Kits (10) and many more products for this protein. A total of 174 TNFRSF10C products are currently listed.
list all antibodies Gene Name GeneID UniProt
TNFRSF10C 8794 O14798

Show all species

Show all synonyms

Most Popular Reactivities for anti-TNFRSF10C (TNFRSF10C) Antibodies

Select your species and application

anti-Human TNFRSF10C Antibodies:

anti-Mouse (Murine) TNFRSF10C Antibodies:

anti-Rat (Rattus) TNFRSF10C Antibodies:

All available anti-TNFRSF10C Antibodies

Go to our pre-filtered search.

Top referenced anti-TNFRSF10C Antibodies

  1. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN4899000 : Barbarotto, Corallini, Rimondi, Fadda, Mischiati, Grill, Vaccarezza, Celeghini: Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. in Journal of cellular biochemistry 2008 (PubMed)
    Show all 11 references for 4899000

  2. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN4895308 : Gojo, Tan, Fang, Sadowska, Lapidus, Baer, Carrier, Beumer, Anyang, Srivastava, Espinoza-Delgado, Ross: Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia. in Clinical cancer research : an official journal of the American Association for Cancer Research 2013 (PubMed)
    Show all 7 references for 4895308

  3. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN238512 : Mérino, Lalaoui, Morizot, Schneider, Solary, Micheau: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. in Molecular and cellular biology 2006 (PubMed)
    Show all 5 references for 238512

  4. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN487315 : Deligezer, Dalay: Expression of the TRAIL receptors in blood mononuclear cells in leukemia. in Pathology oncology research : POR 2007 (PubMed)
    Show all 5 references for 487315

  5. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN487314 : Clancy, Mruk, Archer, Woelfel, Mongkolsapaya, Screaton, Lenardo, Chan: Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. in Proceedings of the National Academy of Sciences of the United States of America 2005 (PubMed)
    Show all 5 references for 487314

  6. Human Monoclonal TNFRSF10C Primary Antibody for ICC, FACS - ABIN1169230 : Wachter, Sprick, Hausmann, Kerstan, McPherson, Stassi, Bröcker, Walczak, Leverkus: cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes. in The Journal of biological chemistry 2004 (PubMed)
    Show all 4 references for 1169230

  7. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN2663243 : Pan, Ni, Wei, Yu, Gentz, Dixit: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. in Science (New York, N.Y.) 1997 (PubMed)
    Show all 3 references for 2663243

  8. Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN1106171 : Baritaki, Katsman, Chatterjee, Yeung, Spandidos, Bonavida: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. in Journal of immunology (Baltimore, Md. : 1950) 2007 (PubMed)
    Show all 2 references for 1106171

  9. Human Polyclonal TNFRSF10C Primary Antibody for WB - ABIN2774599 : Inagaki, Morimura, Tang, Akutagawa, Kida: Tryptophol induces death receptor (DR) 5-mediated apoptosis in U937 cells. in Bioscience, biotechnology, and biochemistry 2007 (PubMed)

More Antibodies against TNFRSF10C Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) interaction partners

  1. High levels of TRAIL-R3 and CCR-2 expression in tumor epithelial cells identified patients with early breast cancer with poor outcomes.

  2. Results identified epigenetic inactivation of TNFRSF10C and TNFRSF10D (show TNFRSF10D Antibodies) in majority of cervical cancer cases.

  3. DcR1 levels in serum sample which were significantly lower in AMD (show AMD1 Antibodies) patients.

  4. DcR1 upregulation mediates temozolomide resistance.

  5. The membrane expression of the TRAIL receptors DR4 (show HLADRB4 Antibodies), DR5 (show TNFRSF10B Antibodies), DcR1 and DcR2 (show CCR6 Antibodies) is greater in normal endometrium than endometrioid adenocarcinoma (EAC (show CYLD Antibodies)). The level of the receptors in EAC (show CYLD Antibodies) is not dependent on grading and staging and does not predict survival.

  6. the results presented here claim for a relevant impact of aberrant methylation of decoy receptors in melanoma and allow to understand how the silencing of DcR1 and DcR2 (show CCR6 Antibodies) is related to melanomagenesis.

  7. GATA4 (show GATA4 Antibodies) and DcR1 promoter hypermethylation is tumor specific event in glioblastoma but they promoter methylation cannot be considered as a prognostic marker of glioblastoma survival.

  8. Primary EOC is associated to a lower TRAIL-R3 expression.

  9. Data show that about 20% of AML (show RUNX1 Antibodies) patients highly expressed decoy receptor TRAIL-R3, which was strongly correlated to a shortened overall survival.

  10. Decoy receptors DcR1 and DcR2 (show CCR6 Antibodies) on CD8 (show CD8A Antibodies)+ T cells, but not on CD4 (show CD4 Antibodies)-positive T cells, are positively correlated with patients' DAS (show ube3a Antibodies) scores.

TNFRSF10C Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.

Alternative names and synonyms associated with TNFRSF10C

  • tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain (TNFRSF10C) antibody
  • CD263 antibody
  • DCR1 antibody
  • DCR1-TNFR antibody
  • LIT antibody
  • TNFRSF10C antibody
  • TRAIL-R3 antibody
  • TRAILR3 antibody
  • TRID antibody

Protein level used designations for TNFRSF10C

TNF-related apoptosis-inducing ligand receptor 3 , antagonist decoy receptor for TRAIL/Apo-2L , cytotoxic TRAIL receptor-3 , decoy TRAIL receptor without death domain , decoy receptor 1 , lymphocyte inhibitor of TRAIL , tumor necrosis factor receptor superfamily member 10C , tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain

8794 Homo sapiens
472713 Pan troglodytes
Selected quality suppliers for anti-TNFRSF10C (TNFRSF10C) Antibodies
Did you look for something else?